Skip to main content
. Author manuscript; available in PMC: 2014 Apr 25.
Published in final edited form as: Trop Med Int Health. 2013 Apr 17;18(7):907–914. doi: 10.1111/tmi.12110

Table 2. Relationship between antiretroviral therapy and treatment outcomes in HIV-infected TB patients.

Time since starting TB treatment Outcomes (%) Treated with ART? Patients treated with ART vs. patients not treated with ART
Yes No Relative risk (95% CI) p-value
Total 314 90
One year Outcome known
Remaining under follow up
Died
Transferred out
Lost to follow up
Stopped ART
297 (95.2)
247 (83.2)
30 (10.1)
13 ( 4.4)
5 ( 1.7)
2 ( 0.7)
86 (95.6)
41 (47.7)
29 (33.7)
13 (15.1)
3 ( 3.5)
-
0.57 ( 0.46 – 0.72)
3.34 ( 2.13 – 5.24)
3.45 ( 1.66 – 7.17)
2.07 ( 0.51 – 8.50)
-
<0.001
<0.001
0.001
0.386
Two years Outcome known
Remaining under follow up
Died
Transferred out
Lost to follow up
Stopped ART
276 (87.9)
208 (75.4)
36 (13.0)
19 ( 6.9)
11 ( 4.0)
2 ( 0.7)
79 (87.8)
22 (27.8)
30 (38.0)
18 (22.8)
9 (11.4)
-
0.37 ( 0.26 – 0.53)
2.91 ( 1.92 – 4.41)
3.31 ( 1.83 – 6.00)
2.86 ( 1.23 – 6.65)
-
<0.001
<0.001
<0.001
0.023
Three years Outcome known
Remaining under follow up
Died
Transferred out
Lost to follow up
Stopped ART
241 (76.8)
159 (66.0)
40 (16.6)
24 ( 10.0)
13 ( 5.4)
5 ( 2.1)
75 (83.3)
15 (20.0)
31 (41.3)
19 ( 25.3)
10 ( 13.3)
-
0.30 ( 0.19 – 0.48)
2.49 ( 1.69 – 3.68)
2.54 ( 1.48 – 4.38)
2.47 ( 1.13 – 5.41)
-
<0.001
<0.001
0.002
0.038

Outcome known = Number of patients at the given time period for whom the outcome is known according to duration of follow up. Follow up ranged from 6 months to five years, depending on time of entry to study.

Remaining under follow up= Continuing to attend regular HIV clinics